|
Measurements
|
T0: baseline
|
T6: end of the intervention
|
T12: Follow up
|
T18: follow up
|
Transition
|
|---|
|
CAARMS
|
X
|
X
|
X
|
X
|
x
|
|
BDI
|
X
|
X
|
X
|
X
|
-
|
|
SIAS
|
X
|
X
|
X
|
X
|
-
|
|
EQ5D
|
x
|
X
|
X
|
X
|
-
|
|
PBIQ-R
|
x
|
X
|
X
|
X
|
-
|
|
MANSA
|
x
|
X
|
X
|
X
|
-
|
|
CDS
|
x
| | |
X
|
x
|
|
Verbal Fluency
|
x
|
X
|
X
|
X
|
-
|
|
Medication check
|
x
|
X
|
X
|
X
|
x
|
|
Blood sample
|
x
|
-
|
-
|
-
|
-
|
|
SCAN interview
|
x
|
-
|
-
|
-
|
x
|
|
PANSS
|
-
|
-
|
-
|
-
|
x
|
|
PSYRATS
|
-
|
-
|
-
|
-
|
x
|
|
Treatment check
|
-
|
-
|
-
|
-
|
x
|
- CAARMS = Comprehensive Assessment of At Risk Mental State; BDI = Beck Depression Inventory; SIAS = Social Interaction Anxiety Scale; EQ5D = Euroqol-5D; PBIQ-R = Personal Beliefs about Illness Questionnaire-Revised; MANSA = Manchester Short Assessment of Quality of Life; CDS = The Calgary Depression Scale; SCAN = Schedules for Clinical Assessment in Neuropsychiatry; PANSS = Positive and Negative Syndrome Scale; PSYRATS = Psychotic Symptom Rating Scales.
